| 000 | 01824 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513054033.0 | ||
| 264 | 0 | _c19950118 | |
| 008 | 199501s 0 0 eng d | ||
| 022 | _a0360-3016 | ||
| 024 | 7 |
_a10.1016/0360-3016(94)00335-i _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDusenbery, K E | |
| 245 | 0 | 0 |
_aRandomized comparison of cyclophosphamide-total body irradiation versus busulfan-cyclophosphamide conditioning in autologous bone marrow transplantation for acute myeloid leukemia. _h[electronic resource] |
| 260 |
_bInternational journal of radiation oncology, biology, physics _cJan 1995 |
||
| 300 |
_a119-28 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBone Marrow Purging _xmethods |
| 650 | 0 | 4 |
_aBone Marrow Transplantation _xmethods |
| 650 | 0 | 4 |
_aBusulfan _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCyclophosphamide _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid _xtherapy |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 | _aWhole-Body Irradiation |
| 700 | 1 | _aDaniels, K A | |
| 700 | 1 | _aMcClure, J S | |
| 700 | 1 | _aMcGlave, P B | |
| 700 | 1 | _aRamsay, N K | |
| 700 | 1 | _aBlazar, B R | |
| 700 | 1 | _aNeglia, J P | |
| 700 | 1 | _aKersey, J H | |
| 700 | 1 | _aWoods, W G | |
| 773 | 0 |
_tInternational journal of radiation oncology, biology, physics _gvol. 31 _gno. 1 _gp. 119-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0360-3016(94)00335-i _zAvailable from publisher's website |
| 999 |
_c7995071 _d7995071 |
||